American Herbal Products Association (AHPA) > News > Latest News

US Marshals seize dietary supplements containing kratom (FDA)

Legal Alert

The U.S. Department of Justice, on behalf of FDA, filed a complaint in U.S. District Court alleging that kratom is a new dietary ingredient (NDI). An FDA spokesperson said that FDA has identified kratom as a substance that could pose a risk to public health and the agency will use its authority to take action on products containing this alleged NDI.

Welcome to our new website!

Redesigned AHPA.org provides instant access, expanded capabilities and increased connection

AHPA is proud to announce the release of its newly designed website. It has been crafted to better reflect our members needs now and also builds upon technology capable of addressing future requirements.

Industry Associations Welcome Elevation of Division of Dietary Supplement Programs to 'Office' within FDA

Press Release

The five trade associations representing the dietary supplement industry today welcomed the elevation of the Division of Dietary Supplement Programs (DDSP) to an "Office" status within the Food and Drug Administration's (FDA) Center for Food Safety and Applied Nutrition (CFSAN).

Global warming and botanicals (Nutrition Business Journal)

Market Alert

"We are entering a new era of weather. And the forecast for ingredient supply is changing just as fast," writes AHPA Member Bill Chioffi in Nutrition Business Journal

FDA warns Miracle in the Green for drug claims

Legal Alert

FDA sent this warning letter to Miracle in the Green for promoting its moringa leaf powder product for conditions that cause the product to be a drug.

FDA warns Nature's Health for drug claims and inadequate responses to alleged cGMP violations

Legal Alert

FDA sent this warning letter to Nature's Health for using drug claims to market herbal products and for inadequate documentation of corrective actions taken to address alleged cGMP violations

Method for the Analysis of Cannabinoids and Terpenes in Cannabis

Cannabis Alert

This research presents an optimized and validated method for the analysis of both terpenes and cannabinoids in cannabis from a single sample preparation.

Warning: Life causes death (Forbes)

Media Alert

The author of this article in Forbes takes a "tongue in cheek" look at what he describes as California's toxic warning labels racket, and its impact on businesses and the public in general

Product safety expert debunks research questioning the safety of dietary supplements at Congressional briefing

Press Release

Research purporting to raise significant questions regarding the safety of dietary supplements often lacks context and appropriate data to draw meaningful conclusions

Effect of Resveratrol Treatment on the Pharmacokinetics of Diclofenac in Healthy Human Volunteers

Science Alert

This limited study assessed the effect of resveratrol on the pharmacokinetics of diclofenac, the nonsteroidal anti-inflammatory drug, in 12 healthy human volunteers
RSS
First 567891011121314 Last

2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.